<?xml version="1.0" encoding="UTF-8"?>
<p>The disease is fairly broadly distributed in China, is tick-borne, and is epidemics in more than 20 provinces [
 <xref rid="pntd.0007829.ref007" ref-type="bibr">7</xref>,
 <xref rid="pntd.0007829.ref008" ref-type="bibr">8</xref>] and with increasing numbers of cases each year [
 <xref rid="pntd.0007829.ref013" ref-type="bibr">13</xref>]. Since the identification of the SFTSV in 2011, all patients are mandatorily reported by doctors within 24 h of diagnosis to the China Information System for Diseases Control and Prevention (CISDCP). In addition to its prevalence in rural area of central and northeastern China, this disease is widely distributed in South Korea [
 <xref rid="pntd.0007829.ref014" ref-type="bibr">14</xref>] and Japan [
 <xref rid="pntd.0007829.ref015" ref-type="bibr">15</xref>], two neighboring countries of China. In addition, other newly emerged phleboviruses were isolated from patients in USA in 2012, including the Heartland virus, a new phlebovirus, which is genetically similar to SFTSV [
 <xref rid="pntd.0007829.ref016" ref-type="bibr">16</xref>]. In 2011â€“2016, a total of 5360 laboratory-confirmed patients were reported to the CISDCP. Annual patient numbers increased yearly and the numbers of affected counties increased sharply from 98 to 167 from 2011 to 2016 [
 <xref rid="pntd.0007829.ref017" ref-type="bibr">17</xref>]. The scope of the disease is expanding, with China being the hardest hit country and the mortality rate remains high.
</p>
